HMGB1 and COVID-19: CLEC3B could bind HMGB1 (the high-mobility group box-1) and reciprocally enhance macrophage endocytosis, thereby induce macrophage pyroptosis, which was proposed as a drug target for sepsis.42 As our data revealed, it could also be a potential drug target for COVID-19 therapy.